GlassScriptPhysician profile
Jeffrey Nelson
NPI 1134414741
$2,564.17
in general payments reported to CMS, 2019-2025
8 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2021: $343 · 2022: $666 · 2023: $422 · 2024: $82.08 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $897 · Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $896.64 |
| Food and Beverage | $276.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,664.87 | 2022-2025 | Clavicular Fracture Fixation, Coalition Mis / Mis Ti, Rod Link Reducer |
| Penumbra, INC. | $276.58 | 2019-2021 | |
| Nuvasive, INC. | $194.96 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $124.54 | 2019 | |
| Depuy Synthes Sales INC. | $119.84 | 2023 | Cerebase |
| Integra Lifesciences Corporation | $115.03 | 2019 | |
| Cordis US Corp. | $54.68 | 2023-2024 | Mynx Venous Vcd, Brite Tip Radianz |
| Stryker Corporation | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.